References
- Bodenhoff Jessie. A new antimycotic from Bayer AG: BAY b 5097. Acta pathologica et microbiologica scandanavica 1971; 79: 345–348, B
- Denny Maire J., Partridge Betty M. Tetrazolium medium as an aid in the routine diagnosis of Candida. Journal of Clinical Pathology 1968; 21: 383–386
- Drouhet E. Some biological activities of antifungal antibiotics and their mode of action. Ciba Foundation Symposium on Systemic Mycoses 1968; 206–240
- Fields B.T., Bates J.H., Abernathy R.S. Amphotericin B serum concentrations during therapy. Applied Microbiology 1970; 19: 955–959
- Garrod L.P., O'Grady F. Antibiotic & Chemotherapy3rd edition. E. & S. Livingstone, London 1971; 236–241
- Grunberg E., Titsworth E., Bennett N. Chemotherapeutic activity of 5-fluorocystosine. Antimicrobial Agents & Chemotherapy 1964; 566–568
- Herrell W.E. The antifungal activity of 5-fluorocytosine. Clinical Medicine February, 1971; 78: 11–13
- The Yeasts — a taxonomic study, J. Lodder. North-Holland, Amsterdam and London 1970
- Marks M.I., Steer P., Eickhoff T.C. In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (BAY 5097). Applied Microbiology 1971; 22: 93–95
- Marks M.I., Eickhoff T.C. Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Antimicrobial Agents & Chemotherapy. 1971; 491–493, 1970
- Oberste-Lehn H., Baggesen I., Plempel M. Preliminary clinical studies of a new oral antimycotic agent in systemic mycosis. German Medical Monthly 1969; 14: 537–539
- Plempel M., Bartmann K., Buchel K.H., Regel E. Experimental study of a new orally effective broad-spectrum antimycotic agent. German Medical Monthly 1969; 14: 532–537
- Plempel M., Bartmann K., Buchel K.H., Regel E. BAY b 5097, a new orally applicable antifungal substance with broad-spectrum activity. Antimicrobial Agents & Chemotherapy. 1970; 271–274, 1969
- Shadomy S. In vitro studies with 5-fluorocytosine. Applied Microbiology 1969; 17: 871–871
- Shadomy S. Further in vitro studies with 5-fluorocytosine. Infection & Immunity 1970; 2: 484–488
- Shadomy S. In vitro antifungal activity of clotrimazole (BAY b 5097). Infection & Immunity 1971; 4: 143–148
- Utz J.P., Tynes B.S., Shadomy Helen J., Duma R.J., Kannan M.M., Mason K.N. 5-fluorocytosine in human cryptococcosis. Antimicrobial Agents & Chemotherapy 1969; 344–346, 1968